CVS Caremark Mail Service Pharmacy- will no longer have inventory to dispense certain supply-constrained GLP-1s.
Summary of Changes
Starting May 15, 2024, CVS Caremark Mail Service Pharmacy will no longer have inventory to dispense any prescriptions for all dosages of the supply-constrained medications below:
- Mounjaro
- Trulicity
- Wegovy
- Saxenda
Impact to Members
- Starting May 15, 2024, members will no longer be able to fill the above supply-constrained GLP-1 drugs at CVS Caremark Mail Service Pharmacy.
- Before May 15, 2024, CVS Caremark’s Mail Service Pharmacy will initiate proactive communication to impacted members:
- Members will receive letters and an outbound call from CVS Caremark Mail Service Customer Care representatives. Communications will alert members to the upcoming change and offer alternative options for members to receive their medication.
- Care representatives will also assist members in transferring prescriptions to any in-network participating retail pharmacy.
- After May 15, 2024, CVS Caremark’s Mail Service Pharmacy will notify members who attempt to fill a prescription for these drugs that their order cannot be processed.
- Multiple communication outreach channels will be used, as permitted: letter, email and/or SMS.
- Prescribers that attempt to send new prescriptions for supply-constrained GLP-1s to CVS Caremark Mail Service Pharmacy will also be notified that the prescription cannot be filled.
- Claims for supply-constrained GLP-1s filled at in-network retail pharmacies will be processed at contracted retail rates. Members will pay retail copays. Commercial members may be eligible to use manufacturer copay cards which could decrease member out of pocket cost.
- Members can view a list of participating pharmacies in their network by signing into Caremark.com. Choose “Plan and Benefits” and then select “Pharmacy Locator.” If they have additional questions, they can call the number on their benefit card.
- MTA has 1352 unique members that will be impacted by this change.
